Pacific Biosciences of California Inc (STU:P09)
€ 2.319 0.068 (3.02%) Market Cap: 639.11 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 57/100

Pacific Biosciences of California Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 09:30PM GMT
Release Date Price: €7.33 (-0.34%)
Rachel Vatnsdal JPMorgan Chase;Co.;Analyst

&-

Perfect. Good afternoon, everyone. This is Rachel Vatnsdal from the life science tools and diagnostics team here at JPMorgan. I'm joined by Christian Henry, President and CEO, PacBio. And so as you've typically seen with most of these sessions, that will be 40 minutes roughly 20 minutes of a presentation followed by 20 minutes of Q&A, if any of you in the room do questions, feel free to either submit them via the portal or you can send them to me directly? And with that, I will pass it off to Christian.

Christian Henry Pacific Biosciences of California
Inc. - President & CEO

Thank you, Rachel, and thank you, JPM, for the opportunity to present in front of all of you today. Also, thank you to all of you for for your attention and your interest in PacBio.

Before we get started, I want to remind folks that we do have we might be making some forward-looking statements, so please refer to our SEC filings as well.

As our website to learn more about the risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot